Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

LEO 39652

😃Good
Catalog No. T38002Cas No. 1445656-91-6

LEO 39652, a dual-soft PDE4 inhibitor, demonstrates potent inhibition of PDE4 subtypes A, B, C, and D with respective IC50 values of 1.2 nM, 1.2 nM, 3.0 nM, and 3.8 nM. Additionally, it inhibits TNF-α with an IC50 of 6.0 nM, indicating its potential for topical Atopic dermatitis (AD) research [1].

LEO 39652

LEO 39652

😃Good
Catalog No. T38002Cas No. 1445656-91-6
LEO 39652, a dual-soft PDE4 inhibitor, demonstrates potent inhibition of PDE4 subtypes A, B, C, and D with respective IC50 values of 1.2 nM, 1.2 nM, 3.0 nM, and 3.8 nM. Additionally, it inhibits TNF-α with an IC50 of 6.0 nM, indicating its potential for topical Atopic dermatitis (AD) research [1].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$1,5206-8 weeks6-8 weeks
50 mg$1,9806-8 weeks6-8 weeks
100 mg$2,5006-8 weeks6-8 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
LEO 39652, a dual-soft PDE4 inhibitor, demonstrates potent inhibition of PDE4 subtypes A, B, C, and D with respective IC50 values of 1.2 nM, 1.2 nM, 3.0 nM, and 3.8 nM. Additionally, it inhibits TNF-α with an IC50 of 6.0 nM, indicating its potential for topical Atopic dermatitis (AD) research [1].
Targets&IC50
PDE4C2:3.0 nM (IC50), PDE4B:1.2 nM (IC50), TNF-α:6.0 nM (IC50), PDE4D:3.8 nM (IC50), PDE4A:1.2 nM (IC50)
In vitro
LEO 39652 exhibits significant unbound in vitro efficacy, as demonstrated by its capacity to inhibit LPS-induced TNF-α release in human peripheral blood mononuclear cells (PBMC) cultured in serum-free medium. Additionally, LEO 39652 demonstrates relatively high affinity for binding to human serum albumin[2].
In vivo
LEO 39652 is inactivated both in blood and liver (dual-soft) while remaining stable in the skin[1]. Pharmacokinetic analysis reveals that LEO 39652 exhibits total clearance (rats 930, minipigs 200, and monkey 300 mL/min/kg) and ratio to total AUC (rats 4, minipigs 6, and monkey 6%) following intravenous administration (rats 0.075, minipigs 0.5, and monkeys 2.0 mg/kg)[1].
Chemical Properties
Molecular Weight421.45
FormulaC23H23N3O5
Cas No.1445656-91-6
SmilesCOc1ccc(-c2ccc3C(=O)OCc3c2)n2nc(nc12)C1(CC1)C(=O)OCC(C)C
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 25 mg/mL (59.32 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3728 mL11.8638 mL23.7276 mL118.6380 mL
5 mM0.4746 mL2.3728 mL4.7455 mL23.7276 mL
10 mM0.2373 mL1.1864 mL2.3728 mL11.8638 mL
20 mM0.1186 mL0.5932 mL1.1864 mL5.9319 mL
50 mM0.0475 mL0.2373 mL0.4746 mL2.3728 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy LEO 39652 | purchase LEO 39652 | LEO 39652 cost | order LEO 39652 | LEO 39652 chemical structure | LEO 39652 in vivo | LEO 39652 in vitro | LEO 39652 formula | LEO 39652 molecular weight